日本の手術用ロボットシステム市場（2025年～2033年）

日本の手術用ロボットシステムの市場規模は、2024年に5億3,962万米ドルに達し、2033年には21億776万米ドルに達する見込みで、2025年～2033年の予測期間中にCAGR16.5％で成長すると予測されています。

手術用ロボットシステムは複雑で高度な医療技術であり、外科医がより高い精度、柔軟性、制御性で外科手術を行うのを支援するために設計されたロボット装置、ソフトウェア、器具で構成されています。これらのシステムは、ロボットアーム、手術器具、視覚化技術、高度な制御システムを使用し、外科医がより効果的で侵襲の少ない方法で低侵襲手術や従来の開腹手術を行うのを支援します。

日本の手術用ロボットシステム市場は、技術の進歩、低侵襲手術の需要の増加、手術結果の改善への注力など、さまざまな要因によって急成長しています。日本における手術用ロボットシステムに対する需要は、さまざまなヘルスケア機関で進化しています。例えば、米国国立衛生研究所（NIH）によると、日本では180以上の医療機関がダヴィンチ手術システムを導入しています。このように手術用ロボットシステムの導入が進んでいることが、日本市場の需要を加速させています。

市場力学：

促進要因と抑制要因

日本における外科手術の増加

日本における外科手術の増加は、日本の手術用ロボットシステム市場の成長を大きく後押ししており、予測期間中も市場を牽引していくと思われます。日本は急速に高齢化が進んでおり、65歳以上の人口が推定3,623万人と3分の1近くを占め、これは主要国の中で最も高い割合です。高齢化に伴い、心血管疾患、がん、整形外科的問題、脊椎疾患などの疾患で複雑な手術が必要になることが多いです。

例えば、Springer Natureが発表した論文によると、日本では2022年に120件の補助人工心臓の移植や79件の心臓移植を含む合計6万1,606件の心臓血管手術が行われました。また、国立医薬品食品衛生研究所によると、日本では1年間に約130万件の整形外科入院手術が行われています。高齢化が進むにつれ、手術件数は増加すると予想され、より良い治療結果を得るために、日本では手術用ロボットシステムの需要が生まれる可能性があります。

心血管系疾患、がん、糖尿病などの慢性疾患は、主に高齢化により日本で増加傾向にあります。これらの疾患は、技術的に困難で高い精度を必要とする大手術を必要とすることが多いです。慢性疾患の負担増は、特に腫瘍学、心臓病学、泌尿器学などの専門分野におけるロボット支援手術の需要を促進しています。外科医は、これらの複雑な手技をより良い結果と少ない合併症で行うためにロボットに依存しており、ロボットシステムの採用を促進しています。

例えば、日本臨床腫瘍学会によると、日本のがん患者数は着実に増加しており、特に前立腺がんは罹患率の主要原因の1つとなっています。東京国際大濠病院によると、現在、日本では300台以上のロボット手術装置が稼働しており、ロボット支援による根治的前立腺摘除術は年間1万3,000例以上行われています。ロボット支援根治的前立腺摘除術やロボット支援腎部分切除術などの泌尿器科ロボット手術は、日本で急速に普及しています。同様に、整形外科、循環器科などの他の手術における手術用ロボットシステムの需要も、予測期間中に増加すると予想されます。

従来の手術システムとの高い競合

従来の手術システムとの競合の高さは、日本の手術用ロボットシステム市場の成長を妨げる要因の1つです。ロボット手術システムは、精度、低侵襲処置、患者転帰の改善において大きな利点を提供しますが、コスト、確立された親しみやすさ、初期投資の低さなどの要因により、日本では伝統的な手術方法が依然として多くの手技を支配しています。

日本における手術用ロボットステムの普及を阻む主な要因のひとつは、初期費用の高さです。ダヴィンチ手術システムやメドトロニック・ヒューゴシステムのような手術用ロボットシステムには多額の初期費用がかかり、その額は数百万米ドルを超えることが多いです。これらのシステムには、高額なメンテナンス、トレーニング、アップグレードも必要です。

例えば、ダヴィンチXi手術システム1台は、継続的なメンテナンスとトレーニング費用を除いて、約100万～250万米ドルかかります。それに比べ、従来の手術システムは格段に安く、多くの腹腔鏡機器システムの価格は5万～20万米ドルで、小規模の病院やヘルスケア施設にとってはより利用しやすいものとなっています。

日本の外科医は一般的に、特に腹腔鏡手術、整形外科、一般外科などの分野で、伝統的な手術手技に高度に熟練しています。これらの手技は確立されたものであり、医療関係者は安心して使うことができます。日本で消化器系の手術に広く用いられている腹腔鏡手術の分野では、外科医は経験豊富で熟練しています。

目次

第1章 市場イントロダクションと範囲

• レポートの目的
• 調査のカバー範囲と定義
• 調査の対象範囲

第2章 エグゼクティブの洞察と重要なポイント

• 市場のハイライトと戦略的ポイント
• 主な動向と将来の予測
• スニペット：タイプ別
• スニペット：用途別
• スニペット：エンドユーザー別

第3章 市場力学

• 影響要因
  • 促進要因
    • 日本における外科手術の増加
  • 抑制要因
    • 従来の外科手術システムとの激しい競合
  • 機会
  • 影響分析

第4章 戦略的洞察と業界展望

• 市場のリーダーと先駆者
  • 新たな先駆者と著名な企業
  • 最大の販売ブランドを持つ確立されたリーダー
  • 確立された製品を持つ市場リーダー
• CXOの視点
• 最新の開発とブレークスルー
• ケーススタディ/進行中の研究
• 規制と償還の情勢
• ポーターのファイブフォース分析
• サプライチェーン分析
• SWOT分析
• アンメットニーズとギャップ
• 市場参入と拡大のための推奨戦略
• シナリオ分析ベストケース、ベースケース、ワーストケースの予測
• 価格分析と価格市場力学
• キーオピニオンリーダー

第5章 手術用ロボットシステム市場：タイプ別

• ロボット支援手術システム
• 外科用ロボットアーム
• 自律型手術用ロボット

第6章 手術用ロボットシステム市場：用途別

• 整形外科
• 婦人科手術
• 泌尿器科手術
• 心臓手術
• 脳神経外科
• 一般外科
• その他

第7章 手術用ロボットシステム市場：エンドユーザー別

• 病院
• 外来手術センター
• 専門クリニック
• その他

第8章 競合情勢と市場ポジショニング

• 競合状況の概要と主要な市場企業
• 市場シェア分析とポジショニングマトリックス
• 戦略的パートナーシップ、合併、買収
• 製品ポートフォリオとイノベーションにおける主な発展
• 企業ベンチマーク

第9章 企業プロファイル

• Medicaroid Corporation
  • 会社概要
  • 製品ポートフォリオと概要
  • 財務概要
  • 主な発展
  • SWOT分析
• Kawasaki Heavy Industries, Ltd.
• TELEXISTENCE Inc.
• Sony Group Corporation
• Intuitive Surgical
• Medtronic plc
• MicroPort Scientific Corporation
• Smith+Nephew
• ASAHI SURGICAL ROBOTICS CO., LTD.

第10章 前提条件と調査手法

• データ収集方法
• データの三角測量
• 予測技術
• データの検証とバリデーション

第11章 付録

The Japan surgical robot systems market reached US$ 539.62 million in 2024 and is expected to reach US$ 2,107.76 million by 2033, growing at a CAGR of 16.5% during the forecast period of 2025-2033.

A surgical robot system is a complex and advanced medical technology that consists of robotic devices, software, and instruments designed to assist surgeons in performing surgical procedures with greater precision, flexibility, and control. These systems use robotic arms, surgical instruments, visualization technologies, and advanced control systems to help surgeons conduct minimally invasive or even traditional open surgeries in a more effective and less invasive manner.

The Japan surgical robot systems Market has seen rapid growth driven by various factors, including advancements in technology, increasing demand for minimally invasive surgeries, and a focus on improving surgical outcomes. The demand for these surgical robot systems in Japan is evolving across different healthcare institutions. For instance, according to the National Institute of Health (NIH), more than 180 institutions have installed the da Vinci surgical system in Japan. This rising adoption of surgical robot systems is accelerating the market demand in Japan.

Market Dynamics: Drivers & Restraints

Rising surgical procedures in Japan

The rising surgical procedures in Japan is significantly driving the growth of the Japan surgical robot systems market and is expected to drive the market over the forecast period. Japan has a rapidly aging population, with almost a third of its population over 65, an estimated 36.23 million, the highest percentage among major economies. As people age, they often require complex surgeries for conditions like cardiovascular diseases, cancer, orthopedic issues, and spinal disorders.

For instance, according to the article published by Springer Nature, a total of 61,606 cardiovascular surgeries, including 120 VAD implantations and 79 heart transplants, were performed in 2022 in Japan. Additionally, according to the National Institute of Health, approximately 1.3 million orthopedic inpatient surgeries were performed in a year in Japan. As the aging population rises, the surgical procedure volume is expected to rise, which may create a demand for surgical robot systems in Japan for better outcomes.

Chronic diseases, such as cardiovascular conditions, cancer, and diabetes, are on the rise in Japan, primarily due to the aging population. These conditions often require major surgeries that can be technically challenging and require high precision. The rising burden of chronic diseases is propelling the demand for robot-assisted surgeries, especially in specialties like oncology, cardiology, and urology. Surgeons rely on robots to perform these complex procedures with better outcomes and fewer complications, driving the adoption of robotic systems.

For instance, according to the Japanese Society of Clinical Oncology, the number of cancer cases in Japan has been steadily increasing, particularly prostate cancer, which is one of the leading causes of morbidity. According to the Tokyo International Ohori Hospital, currently, more than 300 robot surgery units are in operation in Japan, and there have been performed more than 13,000 cases per year of robot-assisted radical prostatectomy. Urological robot surgery, such as robot-assisted radical prostatectomy and robot-assisted partial nephrectomy, is rapidly becoming widespread in Japan. Similarly, the demand for surgical robot systems in other surgeries like orthopedics, cardiology, etc, is expected to rise in the forecast period.

High competition from traditional surgical systems

The high competition from traditional surgical systems is one of the factors hampering the growth of the Japan surgical robot systems market. While robotic surgical systems offer significant advantages in precision, minimally invasive procedures, and improved patient outcomes, traditional surgical methods still dominate many procedures in Japan due to factors like cost, established familiarity, and lower initial investment.

One of the primary barriers to the widespread adoption of robotic surgery systems in Japan is the high initial cost. Surgical robot systems like the da Vinci Surgical System and the Medtronic Hugo System come with significant upfront costs, often exceeding several million dollars. These systems also require costly maintenance, training, and upgrades.

For instance, a single da Vinci Xi Surgical System costs approximately $1 to $2.5 million, not including ongoing maintenance and training costs. In comparison, traditional surgical systems are significantly cheaper, with many laparoscopic equipment systems costing $50,000 to $200,000, making them more accessible for smaller hospitals and healthcare facilities.

Surgeons in Japan are generally highly skilled with traditional surgical techniques, especially in fields like laparoscopic surgery, orthopedics, and general surgery. These techniques are well-established, and medical professionals are comfortable using them. In the field of laparoscopic surgery, which is widely used in Japan for gastrointestinal procedures, surgeons are highly experienced and proficient.

Segment Analysis

The Japan surgical robot systems market is segmented based on type, application, and end-user.

Application:

Orthopedic surgery dominates in the application segment of Japan's surgical robot systems, with the highest market share.

Japan has one of the oldest populations in the world, with almost a third of its population over 65, an estimated 36.23 million, according to the World Economic Forum. As people age, they are more prone to degenerative joint diseases, including osteoarthritis, spinal disorders, and hip and knee joint diseases, all of which require orthopedic surgery.

For instance, according to the National Institute of Health, approximately 1.3 million orthopedic inpatient surgeries were performed in a year in Japan. The demand for joint replacements (especially knee and hip replacements) is rising sharply due to the aging population. As a result, orthopedic surgeries are a major driver for robotic systems, which enhance the precision of joint replacements, reduce recovery times, and improve patient outcomes.

Robotic systems, such as the MAKO Robotic-Arm Assisted Surgery (by Stryker) and RAS (Robot-Assisted Surgery) for knee and hip replacements, are playing a crucial role in transforming orthopedic procedures. These systems offer higher precision during surgeries, better alignment of prosthetics, and improved patient outcomes, which are especially important in joint replacement surgeries.

For instance, the MAKO Robotic-Arm Assisted Surgery system has been increasingly adopted in Japan for knee and hip replacement surgeries. This system allows surgeons to customize procedures based on 3D imaging and offers a greater range of motion and more accurate alignment, resulting in fewer complications and faster recovery times for patients.

Competitive Landscape

The major players in the Japan surgical robot systems market include Medicaroid Corporation, Kawasaki Heavy Industries, Ltd., TELEXISTENCE Inc., Sony Group Corporation, Intuitive Surgical, Medtronic plc, MicroPort Scientific Corporation, Smith+Nephew, ASAHI SURGICAL ROBOTICS CO., LTD., and others.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyze product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Japan surgical robot systems market report delivers a detailed analysis with 36 key tables, more than 30 visually impactful figures, and 158 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

• 1.1. Objectives of the Report
• 1.2. Report Coverage & Definitions
• 1.3. Report Scope

2. Executive Insights and Key Takeaways

• 2.1. Market Highlights and Strategic Takeaways
• 2.2. Key Trends and Future Projections
• 2.3. Snippet by Type
• 2.4. Snippet by Application
• 2.5. Snippet by End-User

3. Dynamics

• 3.1. Impacting Factors
  • 3.1.1. Drivers
    • 3.1.1.1. Rising surgical procedures in Japan
  • 3.1.2. Restraints
    • 3.1.2.1. High competition from traditional surgical systems
  • 3.1.3. Opportunity
  • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

• 4.1. Market Leaders and Pioneers
  • 4.1.1. Emerging Pioneers and Prominent Players
  • 4.1.2. Established leaders with largest selling Brand
  • 4.1.3. Market leaders with established Product
• 4.2. CXO Perspectives
• 4.3. Latest Developments and Breakthroughs
• 4.4. Case Studies/Ongoing Research
• 4.5. Regulatory and Reimbursement Landscape
• 4.6. Porter's Five Forces Analysis
• 4.7. Supply Chain Analysis
• 4.8. SWOT Analysis
• 4.9. Unmet Needs and Gaps
• 4.10. Recommended Strategies for Market Entry and Expansion
• 4.11. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
• 4.12. Pricing Analysis and Price Dynamics
• 4.13. Key Opinion Leaders

5. Surgical Robot Systems Market, By Type

• 5.1. Introduction
  • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 5.1.2. Market Attractiveness Index, By Type
• 5.2. Robotic-Assisted Surgical Systems*
  • 5.2.1. Introduction
  • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 5.3. Surgical Robotic Arms
• 5.4. Autonomous Surgical Robots

6. Surgical Robot Systems Market, By Application

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 6.1.2. Market Attractiveness Index, By Application
• 6.2. Orthopedic Surgery*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Gynecology Surgery
• 6.4. Urological Surgery
• 6.5. Cardiac Surgery
• 6.6. Neurosurgery
• 6.7. General Surgery
• 6.8. Others

7. Surgical Robot Systems Market, By End-User

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 7.1.2. Market Attractiveness Index, By End-User
• 7.2. Hospitals*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Ambulatory Surgical Centers
• 7.4. Specialty Clinics
• 7.5. Others

8. Competitive Landscape and Market Positioning

• 8.1. Competitive Overview and Key Market Players
• 8.2. Market Share Analysis and Positioning Matrix
• 8.3. Strategic Partnerships, Mergers, & Acquisitions
• 8.4. Key Developments in Product Portfolios and Innovations
• 8.5. Company Benchmarking

9. Company Profiles

• 9.1. Medicaroid Corporation*
  • 9.1.1. Company Overview
  • 9.1.2. Product Portfolio and Description
  • 9.1.3. Financial Overview
  • 9.1.4. Key Developments
  • 9.1.5. SWOT Analysis
• 9.2. Kawasaki Heavy Industries, Ltd.
• 9.3. TELEXISTENCE Inc.
• 9.4. Sony Group Corporation
• 9.5. Intuitive Surgical
• 9.6. Medtronic plc
• 9.7. MicroPort Scientific Corporation
• 9.8. Smith+Nephew
• 9.9. ASAHI SURGICAL ROBOTICS CO., LTD.

LIST NOT EXHAUSTIVE

10. Assumption and Research Methodology

• 10.1. Data Collection Methods
• 10.2. Data Triangulation
• 10.3. Forecasting Techniques
• 10.4. Data Verification and Validation

11. Appendix

• 11.1. About Us and Services
• 11.2. Contact Us